These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2427535)

  • 1. Hematologic malignancies: non-Hodgkin's lymphomas.
    DeVita VT
    Hosp Pract (Off Ed); 1986 Sep; 21(9):103-18. PubMed ID: 2427535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D; Vandenheule B; Stryckmans P
    Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Björkholm M; Celsing F; Johansson E;
    Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for Hodgkin's disease.
    Ekert H
    N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 7. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
    Fisher RI; Young RC; Longo D; DeVita VT
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):29-32. PubMed ID: 2579441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid drugs: their role in oncological practice.
    Lowenthal RM; Jestrimski KW
    Med J Aust; 1986 Jan; 144(2):81-5. PubMed ID: 2417096
    [No Abstract]   [Full Text] [Related]  

  • 10. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematologic tumors].
    Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy for non-Hodgkin's lymphoma].
    Kuraishi Y; Usui N; Dobashi N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2210-6. PubMed ID: 9881077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
    Gaynor ER; Fisher RI
    Oncology (Williston Park); 1995 Dec; 9(12):1273-9; discussion 1283-4. PubMed ID: 8771102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K; Honda T; Hattori M
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E
    Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.